<DOC>
	<DOCNO>NCT00301509</DOCNO>
	<brief_summary>To evaluate : 1. impact combine antiviral therapy ( Peginterferon plus ribavirin ) natural history patient affect HCV decompensated cirrhosis , sustain virological response . A controlled study . 2. safety efficacy antiviral therapy population use statistically significally number patient control .</brief_summary>
	<brief_title>Antiviral Therapy Decompensated Hepatitis C Virus ( HCV ) Cirrhosis</brief_title>
	<detailed_description>Decompensated HCV cirrhosis relevant problem clinical evidence predispose high mortality risk , survival rate 50 % 5 year ( 1,2 ) . Davis et . al process mathematical model natural history chronic hepatitis C project total number case cirrhosis increase 50 % 2010 plateaued ( 3 ) . As result , dramatic increase number case complication liver failure decompensated event cirrhosis increase 25 % 2010 , 32 % 2020 , 36 % 2030 , 38 % 2040 ( 3 , table 1 ) .Liver transplantation treatment choice limit number organ donor make realizable major patient . Furthermore , age 65 year correlate disease accept enter list liver transplant . To prevent patient worsen liver disease positive economic implication term health care resource use diagnostic test , clinic visit , drug therapy , hospitalization management complication , later , liver transplantation , indirect cost relate lost work time impaired quality life . control study antiviral treatment decompensated cirrhotics show HCV clearance therapy life-saving , improve hepatic function , reduce disease progression . Treatment encourage CTP class A B , especially patient infect genotype 2 . The benefit treat patient genotype 1 remains unproven .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Cirrhosis , Experimental</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<criteria>HCV cirrhotics admit hospital decompensated event , ascites , variceal bleeding , hepatic encephalopathy rapid deterioration liver and/or renal function , detection hepatocarcinoma , infection HIV HBV virus , current alcohol drug abuse , chronic invalidating disease , bacterial infection , platelet &lt; 35,000 cells/μL , neutrophils &lt; 1,000 cells/μL , haemoglobin level &lt; 10 g/dL , total bilirubin &gt; 3 mg/dL , serum creatinine &gt; 2.0 mg/dL .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2005</verification_date>
</DOC>